img

Global Prostacyclin Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prostacyclin Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
Prostacyclin Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prostacyclin Drug market is projected to reach US$ 3102.8 million in 2029, increasing from US$ 2367 million in 2022, with the CAGR of 4.0% during the period of 2024 to 2029. Demand from For Injection and For Oral are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prostacyclin Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Segment by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium

Segment by Application


For Injection
For Oral
For Inhalation

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Prostacyclin Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prostacyclin Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prostacyclin Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prostacyclin Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prostacyclin Drug introduction, etc. Prostacyclin Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Prostacyclin Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Prostacyclin Drug Market Overview
1.1 Prostacyclin Drug Product Overview
1.2 Prostacyclin Drug Market Segment by Type
1.2.1 Epoprostenol Sodium
1.2.2 Treprostinil
1.2.3 Iloprost
1.2.4 Beraprost Sodium
1.3 Global Prostacyclin Drug Market Size by Type
1.3.1 Global Prostacyclin Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Prostacyclin Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Prostacyclin Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prostacyclin Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Prostacyclin Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Prostacyclin Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Prostacyclin Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Prostacyclin Drug Sales Breakdown by Type (2018-2024)
2 Global Prostacyclin Drug Market Competition by Company
2.1 Global Top Players by Prostacyclin Drug Sales (2018-2024)
2.2 Global Top Players by Prostacyclin Drug Revenue (2018-2024)
2.3 Global Top Players by Prostacyclin Drug Price (2018-2024)
2.4 Global Top Manufacturers Prostacyclin Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prostacyclin Drug Market Competitive Situation and Trends
2.5.1 Prostacyclin Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Prostacyclin Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostacyclin Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Prostacyclin Drug Market
2.8 Key Manufacturers Prostacyclin Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prostacyclin Drug Status and Outlook by Region
3.1 Global Prostacyclin Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Prostacyclin Drug Historic Market Size by Region
3.2.1 Global Prostacyclin Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Prostacyclin Drug Sales in Value by Region (2018-2024)
3.2.3 Global Prostacyclin Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Prostacyclin Drug Forecasted Market Size by Region
3.3.1 Global Prostacyclin Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Prostacyclin Drug Sales in Value by Region (2024-2029)
3.3.3 Global Prostacyclin Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Prostacyclin Drug by Application
4.1 Prostacyclin Drug Market Segment by Application
4.1.1 For Injection
4.1.2 For Oral
4.1.3 For Inhalation
4.2 Global Prostacyclin Drug Market Size by Application
4.2.1 Global Prostacyclin Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Prostacyclin Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Prostacyclin Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prostacyclin Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Prostacyclin Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Prostacyclin Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Prostacyclin Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Prostacyclin Drug Sales Breakdown by Application (2018-2024)
5 North America Prostacyclin Drug by Country
5.1 North America Prostacyclin Drug Historic Market Size by Country
5.1.1 North America Prostacyclin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Prostacyclin Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Prostacyclin Drug Sales in Value by Country (2018-2024)
5.2 North America Prostacyclin Drug Forecasted Market Size by Country
5.2.1 North America Prostacyclin Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Prostacyclin Drug Sales in Value by Country (2024-2029)
6 Europe Prostacyclin Drug by Country
6.1 Europe Prostacyclin Drug Historic Market Size by Country
6.1.1 Europe Prostacyclin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Prostacyclin Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Prostacyclin Drug Sales in Value by Country (2018-2024)
6.2 Europe Prostacyclin Drug Forecasted Market Size by Country
6.2.1 Europe Prostacyclin Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Prostacyclin Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Prostacyclin Drug by Region
7.1 Asia-Pacific Prostacyclin Drug Historic Market Size by Region
7.1.1 Asia-Pacific Prostacyclin Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Prostacyclin Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Prostacyclin Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Prostacyclin Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Prostacyclin Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Prostacyclin Drug Sales in Value by Region (2024-2029)
8 Latin America Prostacyclin Drug by Country
8.1 Latin America Prostacyclin Drug Historic Market Size by Country
8.1.1 Latin America Prostacyclin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Prostacyclin Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Prostacyclin Drug Sales in Value by Country (2018-2024)
8.2 Latin America Prostacyclin Drug Forecasted Market Size by Country
8.2.1 Latin America Prostacyclin Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Prostacyclin Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Prostacyclin Drug by Country
9.1 Middle East and Africa Prostacyclin Drug Historic Market Size by Country
9.1.1 Middle East and Africa Prostacyclin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Prostacyclin Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Prostacyclin Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Prostacyclin Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Prostacyclin Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Prostacyclin Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 United Therapeutics
10.1.1 United Therapeutics Company Information
10.1.2 United Therapeutics Introduction and Business Overview
10.1.3 United Therapeutics Prostacyclin Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 United Therapeutics Prostacyclin Drug Products Offered
10.1.5 United Therapeutics Recent Development
10.2 Actelion (J & J)
10.2.1 Actelion (J & J) Company Information
10.2.2 Actelion (J & J) Introduction and Business Overview
10.2.3 Actelion (J & J) Prostacyclin Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Actelion (J & J) Prostacyclin Drug Products Offered
10.2.5 Actelion (J & J) Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Prostacyclin Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GSK Prostacyclin Drug Products Offered
10.3.5 GSK Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Prostacyclin Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Teva Prostacyclin Drug Products Offered
10.4.5 Teva Recent Development
10.5 Toray
10.5.1 Toray Company Information
10.5.2 Toray Introduction and Business Overview
10.5.3 Toray Prostacyclin Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Toray Prostacyclin Drug Products Offered
10.5.5 Toray Recent Development
10.6 Tide Pharma
10.6.1 Tide Pharma Company Information
10.6.2 Tide Pharma Introduction and Business Overview
10.6.3 Tide Pharma Prostacyclin Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Tide Pharma Prostacyclin Drug Products Offered
10.6.5 Tide Pharma Recent Development
10.7 Bayer AG
10.7.1 Bayer AG Company Information
10.7.2 Bayer AG Introduction and Business Overview
10.7.3 Bayer AG Prostacyclin Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Bayer AG Prostacyclin Drug Products Offered
10.7.5 Bayer AG Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prostacyclin Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prostacyclin Drug Industrial Chain Analysis
11.4 Prostacyclin Drug Market Dynamics
11.4.1 Prostacyclin Drug Industry Trends
11.4.2 Prostacyclin Drug Market Drivers
11.4.3 Prostacyclin Drug Market Challenges
11.4.4 Prostacyclin Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prostacyclin Drug Distributors
12.3 Prostacyclin Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Epoprostenol Sodium
Table 2. Major Company of Treprostinil
Table 3. Major Company of Iloprost
Table 4. Major Company of Beraprost Sodium
Table 5. Global Prostacyclin Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Prostacyclin Drug Sales by Type (2018-2024) & (K Units)
Table 7. Global Prostacyclin Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Prostacyclin Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Prostacyclin Drug Market Share in Value by Type (2018-2024)
Table 10. Global Prostacyclin Drug Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Prostacyclin Drug Sales by Type (2024-2029) & (K Units)
Table 12. Global Prostacyclin Drug Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Prostacyclin Drug Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Prostacyclin Drug Sales Market Share in Value by Type (2024-2029)
Table 15. Global Prostacyclin Drug Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Prostacyclin Drug Sales by Type (2018-2024) & (K Units)
Table 17. North America Prostacyclin Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Prostacyclin Drug Sales (K Units) by Type (2018-2024)
Table 19. Europe Prostacyclin Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Prostacyclin Drug Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Prostacyclin Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Prostacyclin Drug Sales (K Units) by Type (2018-2024)
Table 23. Latin America Prostacyclin Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Prostacyclin Drug Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Prostacyclin Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Prostacyclin Drug Sales by Company (2018-2024) & (K Units)
Table 27. Global Prostacyclin Drug Sales Share by Company (2018-2024)
Table 28. Global Prostacyclin Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Prostacyclin Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Prostacyclin Drug Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Prostacyclin Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Prostacyclin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostacyclin Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Prostacyclin Drug Market
Table 35. Key Manufacturers Prostacyclin Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Prostacyclin Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Prostacyclin Drug Sales by Region (2018-2024) & (K Units)
Table 39. Global Prostacyclin Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Prostacyclin Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Prostacyclin Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Prostacyclin Drug Sales by Region (2024-2029) & (K Units)
Table 44. Global Prostacyclin Drug Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Prostacyclin Drug Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Prostacyclin Drug Sales Market Share in Value by Region (2024-2029)
Table 47. Global Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Prostacyclin Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Prostacyclin Drug Sales by Application (2018-2024) & (K Units)
Table 50. Global Prostacyclin Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Prostacyclin Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Prostacyclin Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Prostacyclin Drug Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Prostacyclin Drug Sales by Application (2024-2029) & (K Units)
Table 55. Global Prostacyclin Drug Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Prostacyclin Drug Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Prostacyclin Drug Sales Market Share in Value by Application (2024-2029)
Table 58. Global Prostacyclin Drug Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Prostacyclin Drug Sales by Application (2018-2024) (K Units)
Table 60. North America Prostacyclin Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Prostacyclin Drug Sales by Application (2018-2024) (K Units)
Table 62. Europe Prostacyclin Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Prostacyclin Drug Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Prostacyclin Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Prostacyclin Drug Sales by Application (2018-2024) (K Units)
Table 66. Latin America Prostacyclin Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Prostacyclin Drug Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Prostacyclin Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Prostacyclin Drug Sales by Country (2018-2024) & (K Units)
Table 70. North America Prostacyclin Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Prostacyclin Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Prostacyclin Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Prostacyclin Drug Sales by Country (2024-2029) & (K Units)
Table 74. North America Prostacyclin Drug Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Prostacyclin Drug Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Prostacyclin Drug Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Prostacyclin Drug Sales by Country (2018-2024) & (K Units)
Table 78. Europe Prostacyclin Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Prostacyclin Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Prostacyclin Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Prostacyclin Drug Sales by Country (2024-2029) & (K Units)
Table 82. Europe Prostacyclin Drug Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Prostacyclin Drug Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Prostacyclin Drug Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Prostacyclin Drug Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Prostacyclin Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Prostacyclin Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Prostacyclin Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Prostacyclin Drug Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Prostacyclin Drug Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Prostacyclin Drug Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Prostacyclin Drug Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Prostacyclin Drug Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Prostacyclin Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Prostacyclin Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Prostacyclin Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Prostacyclin Drug Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Prostacyclin Drug Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Prostacyclin Drug Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Prostacyclin Drug Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Prostacyclin Drug Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Prostacyclin Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Prostacyclin Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Prostacyclin Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Prostacyclin Drug Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Prostacyclin Drug Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Prostacyclin Drug Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Prostacyclin Drug Sales Market Share in Value by Country (2024-2029)
Table 109. United Therapeutics Company Information
Table 110. United Therapeutics Introduction and Business Overview
Table 111. United Therapeutics Prostacyclin Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. United Therapeutics Prostacyclin Drug Product
Table 113. United Therapeutics Recent Development
Table 114. Actelion (J & J) Company Information
Table 115. Actelion (J & J) Introduction and Business Overview
Table 116. Actelion (J & J) Prostacyclin Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Actelion (J & J) Prostacyclin Drug Product
Table 118. Actelion (J & J) Recent Development
Table 119. GSK Company Information
Table 120. GSK Introduction and Business Overview
Table 121. GSK Prostacyclin Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. GSK Prostacyclin Drug Product
Table 123. GSK Recent Development
Table 124. Teva Company Information
Table 125. Teva Introduction and Business Overview
Table 126. Teva Prostacyclin Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Teva Prostacyclin Drug Product
Table 128. Teva Recent Development
Table 129. Toray Company Information
Table 130. Toray Introduction and Business Overview
Table 131. Toray Prostacyclin Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Toray Prostacyclin Drug Product
Table 133. Toray Recent Development
Table 134. Tide Pharma Company Information
Table 135. Tide Pharma Introduction and Business Overview
Table 136. Tide Pharma Prostacyclin Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Tide Pharma Prostacyclin Drug Product
Table 138. Tide Pharma Recent Development
Table 139. Bayer AG Company Information
Table 140. Bayer AG Introduction and Business Overview
Table 141. Bayer AG Prostacyclin Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Bayer AG Prostacyclin Drug Product
Table 143. Bayer AG Recent Development
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Prostacyclin Drug Market Trends
Table 147. Prostacyclin Drug Market Drivers
Table 148. Prostacyclin Drug Market Challenges
Table 149. Prostacyclin Drug Market Restraints
Table 150. Prostacyclin Drug Distributors List
Table 151. Prostacyclin Drug Downstream Customers
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostacyclin Drug Product Picture
Figure 2. Global Prostacyclin Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Prostacyclin Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Prostacyclin Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Epoprostenol Sodium
Figure 6. Global Epoprostenol Sodium Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Treprostinil
Figure 8. Global Treprostinil Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Iloprost
Figure 10. Global Iloprost Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Beraprost Sodium
Figure 12. Global Beraprost Sodium Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Prostacyclin Drug Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Prostacyclin Drug Sales Market Share by Type in 2022 & 2029
Figure 15. North America Prostacyclin Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Prostacyclin Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Prostacyclin Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Prostacyclin Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Prostacyclin Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Prostacyclin Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Prostacyclin Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Prostacyclin Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Prostacyclin Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Prostacyclin Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostacyclin Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostacyclin Drug Revenue in 2022
Figure 27. Prostacyclin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of For Injection
Figure 29. Global For Injection Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of For Oral
Figure 31. Global For Oral Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of For Inhalation
Figure 33. Global For Inhalation Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Prostacyclin Drug Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Prostacyclin Drug Sales Market Share by Application in 2022 & 2029
Figure 36. North America Prostacyclin Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Prostacyclin Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Prostacyclin Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Prostacyclin Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Prostacyclin Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Prostacyclin Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Prostacyclin Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Prostacyclin Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Prostacyclin Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Prostacyclin Drug Manufacturing Cost Structure
Figure 47. Prostacyclin Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed